The role of visfatin as an inflammatory biomarker in various diseases such as diabetes [13], inflammatory bowel disease [11], rheumatoid arthritis [57], and cardiovascular diseases [58] has been clarified. This evidence concerns the gene NAMPT and inflammatory bowel disease.